|
NDUFAF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60850222030717E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.80079959225077E-10 |
| Normal-vs-Stage2 |
2.788400E-01 |
| Normal-vs-Stage3 |
1.50990331349021E-14 |
| Normal-vs-Stage4 |
2.18225437720321E-12 |
| Stage1-vs-Stage2 |
2.280200E-02 |
| Stage1-vs-Stage3 |
1.306150E-02 |
| Stage1-vs-Stage4 |
1.290020E-02 |
| Stage2-vs-Stage3 |
2.740900E-03 |
| Stage2-vs-Stage4 |
1.375130E-03 |
| Stage3-vs-Stage4 |
3.878600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.25010000024051E-07 |
| Normal-vs-Asian |
9.36220000413712E-08 |
| Caucasian-vs-AfricanAmerican |
8.866200E-01 |
| Caucasian-vs-Asian |
4.148200E-01 |
| AfricanAmerican-vs-Asian |
7.111000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90769622321341E-11 |
| Normal-vs-Female |
1.14020015651306E-10 |
| Male-vs-Female |
1.077440E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.50700049398267E-10 |
| Normal-vs-Age(41-60Yrs) |
1.54820600783978E-12 |
| Normal-vs-Age(61-80Yrs) |
1.95706999999157E-05 |
| Normal-vs-Age(81-100Yrs) |
3.64470000000505E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.200000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.674220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.409600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.702250E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.126600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.658400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.670190E-01 |
| Classical-VS-Follicular |
3.807700E-04 |
| Classical-VS-Other |
3.486400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
6.45999999999702E-05 |
| Tall-VS-Other |
6.117200E-01 |
| Tall-VS-Normal |
4.18554080283684E-14 |
| Follicular-VS-Other |
1.027620E-02 |
| Follicular-VS-Normal |
5.366300E-02 |
| Other-VS-Normal |
5.61119999999971E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92250004804606E-09 |
| Normal-vs-N1 |
2.14273043752655E-14 |
| N0-vs-N1 |
2.217800E-03 |
|
|
